HORSHAM, Pa.--(BUSINESS WIRE)--
NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (QSII) today offered a statement in response to the Centers for Medicare & Medicaid Services (CMS) release of the long-anticipated final rule for implementing the MACRA law passed in 2015.
In response to the MACRA Final Rule announcement, Rusty Frantz, NextGen Healthcare president and CEO, said, “NextGen Healthcare is fully-committed to supporting our clients through this transition. We have proactively developed a comprehensive suite of tools and a support infrastructure that includes complimentary education programs, a value-based readiness survey to assess a client’s current state, as well as full consulting services to help guide clients and ensure they optimize reimbursement under the MACRA program.”
Education webinars for clients about MACRA and Value-Based Care begin next week and our NextGen User Group Meeting, which will be held Nov. 6-9, 2016, will focus on MACRA and Value-Based Care. In addition to numerous education and training sessions on these topics, NextGen Healthcare will provide MACRA readiness assessments for attendees, with a goal to help clients identify needs so together we can create a customized plan and choose which reimbursement path they will take. Clients can still register to attend NextGen ONE UGM here.
For more information on MACRA and value-based care visit www.nextgen.com/MACRA.
About NextGen Healthcare
NextGen Healthcare, a wholly owned subsidiary of Quality Systems, Inc., helps ambulatory care organizations succeed in value-based care by empowering them to nurture measurably healthier patients and communities at a lower cost. It does this with deep clinical, financial, operational, and regulatory expertise, using consulting and educational services coupled with a robust technology portfolio of flexible, scalable, and cost-effective ambulatory solutions; including a certified EHR, practice management, interoperability, care management, patient engagement and population health management, analytics, e-transaction, and revenue cycle management solutions. For more information, visit www.nextgen.com. Follow NextGen Healthcare on Twitter, Facebook, or LinkedIn.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments in the healthcare sector and regulatory framework, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income, and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2016 and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.